Schindler, Aaron
Denecke, Timm
Seehofer, Daniel
van Bömmel, Florian
Berg, Thomas
Funding for this research was provided by:
Universität Leipzig
Article History
Received: 16 September 2025
Accepted: 22 September 2025
First Online: 25 October 2025
Declarations
:
: Aaron Schindler has nothing to disclose. Timm Denecke has nothing to disclose. Daniel Seehofer declares honoraria for lectures and/or as an advisor from Chiesi, Olympus, Astellas, Novartis, SIRTEX, BTG, Johnson & Johnson. Florian van Bömmel declares honoraria from honoraria for lectures and/or as an advisor from ADVANZ Pharma, Astra Zeneca, Bayer, BMS, Falk Foundation, Gilead Sciences, MSD, Novartis, Roche and StreamedUp!. Thomas Berg receipt of grants/research supports from Abbvie, BMS, Gilead, MSD/Merck, Humedics, Intercept, Merz, Norgine, Novartis, Orphalan, Sequana Medical; honoraria or consultation fees/advisory board: from Abbvie, Alexion, Albireo, Bayer, Gilead, GSK, Eisai, Enyo Pharma, HepaRegeniX GmbH, Humedics, Intercept, Ipsen, Janssen, MSD/Merck, Novartis, Orphalan, Roche, Sequana Medical, SIRTEX, SOBI, and Shionogi and participated in a company sponsored speaker’s bureau: Abbvie, Advance Pharma, Alexion, Albireo, Bayer, Gilead, Eisai, Falk Foundation, Intercept, Ipsen, Janssen, MedUpdate GmbH, MSD/Merck, Novartis, Orphalan, Sequana Medica, SIRTEX, and SOBI. The authors declare no competing interests.